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Parasitemia Characteristics of Plasmodium vivax Malaria 
Patients in the Republic of Korea
Parasitemia characteristics of Plasmodium vivax malaria in temperate regions may differ 
from those in tropical zones. However, most parasitological and clinical features of P. vivax 
malaria have been investigated in the latter. In this study, we investigated 383 malaria 
patients to clarify the parasitemia characteristics of a P. vivax strain in the Republic of 
Korea (ROK). The mean parasitemia (8,396/µL) was less than half of tropical P. vivax 
malaria, and multiple invasions of erythrocytes were not rare (53.5% of the patients, 2.4% 
of the total investigated RBCs), but less than the observations in tropical zones. The 
intervals between the first symptom onset and diagnosis were significantly longer in 
gametocyte (+) patients than in gametocyte (-) patients. Only half of the total patients had 
both genders of gametocytes (191 of 353), and the male gametocyte density (169/µL) was 
lower than that of P. vivax strains of a previous study. Multiple invasions of erythrocytes 
and gametocytemia were coincident factors of the degree of anemia in P. vivax malaria. 
The present findings demonstrate the P. vivax strain in ROK reveals relatively low 
parasitemia and low male to female gametocyte ratio. The low ratio may be related with 
low transmission efficacy. 
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INTRODUCTION
Malaria is the most prevalent parasitic disease in the world. Each 
year 300 to 500 million cases occur worldwide, and approximate-
ly one to three million people die of malaria (1, 2). Among the 
four species of human Plasmodium, P. vivax, which causes ma-
laria in temperate zones and also in large areas of tropical re-
gions, is the second most common species. P. vivax malaria 
was endemic until the early 1970s in the Korean Peninsula (3-5), 
and re-emerged in the Republic of Korea (ROK) in 1993 (6, 7). 
Based on epidemiological data, re-emergence of P. vivax malar-
ia in ROK was ascribed to infected mosquitoes originating from 
North Korea. Since the re-emergence, nearly a million cases of 
P. vivax malaria have occurred in ROK and North Korea (6, 8- 
10), and the malaria situation of ROK and North Korea provides 
a favorable environment to elucidate the parasitemia character-
istics of P. vivax malaria. Many parasitemia and clinical features 
of P. vivax malaria have been investigated so far, but most of the 
data have been acquired from tropical regions. Transmission 
and symptom development of P. vivax malaria in temperate 
zones are largely influenced by seasonal change, whereas such 
seasonal interruption is less obvious in tropical zones. Therefore, 
parasitemia characteristics of P. vivax malaria in temperate zones 
may be quite different from those in tropical zones. However, 
data from temperate regions have been scarce except those ac-
quired from malaria therapy by artificially induced infection for 
neurosyphilis patients (11-13). In that therapy, the number of 
inoculums was higher than in natural infections, which might Huh A-J, et al.  •  Parasitemia Characteristics of P. vivax Malaria in Korea
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have resulted in clinical and parasitemia differences from natu-
ral infections.
  The concentrated occurrence of P. vivax malaria near the 
Demilitarized Zone between ROK and North Korea provides a 
good opportunity to better understand the parasitemia charac-
teristics of P. vivax malaria in a temperate zone. Parasitemia 
characteristics including gametocytemia feature is the impor-
tant factor related to clinical manifestation and transmission 
efficacy of Plasmodium. In this study, we investigated the Gi-
emsa-stained peripheral blood smears and clinical laboratory 
data of P. vivax malaria patients in ROK to clarify the parasit-
emia characteristics of the P. vivax strain in ROK.
MATERIALS AND METHODS
Subjects enrolled in this study were P. vivax malaria patients 
who were diagnosed during 2002-2006 at six private hospitals 
located in the northwestern malaria-prevalent areas in ROK. All 
of the 383 patients were civilians or veterans. The diagnoses were 
made by microscopic examination of Giemsa-stained periph-
eral blood smears. Multiple invasion and parasitemia were cal-
culated by microscopic examination of 1,000 thin film fields at 
1,000 × magnification. Patients’ epidemiological and demogra-
phic data were obtained from clinical records. Parasitemia char-
acteristics were elucidated by examination of the patients’ peri-
pheral blood smears prepared when the disease was diagnosed. 
Hematological and serological data at the time of diagnosis were 
also obtained from clinical records. No patient was undergoing 
chemoprophylaxis when they visited the hospitals. Any addi-
tional examination or blood collection was not performed for 
the sake of this study and all protocols were approved by the in-
stitutional review board of each hospital.
  Statistical analyses were performed using the chi-square test 
without any assumption about the distribution of data using 
SPSS (Statistical Products and Service Solutions, Chicago, IL, 
USA). Continuous variables were compared by the Student’s t 
test and Mann-Whitney U tests. Statistical significance was de-
fined as a P value < 0.05.
 
RESULTS
Of the 383 P. vivax malaria patients enrolled in this study, 283 
(74%) were male and the remaining 100 were female (Fig. 1A). 
Median age of the patients was 39 yr (range, 14-89). More than 
half of the patients were in their 20 sec (104/383) and 40 sec (102/ 
383) representing 27.2% and 26.6% of the study population, re-
spectively. The next populated age group was in their 30 sec 
(19.8%, 76/383). Most patients (96%) in this study presented at 
the hospitals between May and October (Fig. 1B). The mean par-
asitemia was 8,396/µL with the minimum and the maximum of 
12/µL and 140,994/µL, respectively (Table 1). Approximately 
half of the patients (50.9%) showed parasitemia between 1,000-
10,000/µL, with the remainder showing either more than 10,000/ 
µL or less than 1,000/µL.
  Gametocytes were found in 92.2% of the patients (Table 2). 
Parasitemias were significantly higher in gametocyte (+) patients 
than in gametocyte (-) patients. Intervals between the onset of 
the first symptom and diagnosis were also significantly longer 
in gametocyte (+) patients (P = 0.001). The anemia markers, red 
blood cell (RBC) counts, hemoglobin, and hematocrit levels, 
were significantly higher in gametocyte (-) patients.
  Multiple invasions, which refer to infection of one RBC by 
Table 1. Distribution of parasitemia of the Plasmodium vivax malaria patients (N=383) 
enrolled in this study*
Parasitemia (No./µL) No. of patients (%)
No. < 100 10 (2.6)
100 ≤ No. < 1,000   81 (21.2)
1,000 ≤ No. < 10,000 195 (50.9)
10,000 ≤ No. < 100,000   94 (24.5)
100,000 ≤ No.   3 (0.8)
Mean parasitemia (± standard deviation), 8,396 (± 15,800). *The minimum and the 
maximum parasitemia were 12/µL and 140,994/µL, respectively. 
Fig. 1. Demographic and epidemiological characteristics of the Plasmodium vivax malaria patients enrolled in this study. Age and gender distribution (A), Monthly and annual 
numbers (B).
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multiple ring forms, occurred in 53.5% of the patients (Table 3). 
The intervals between the onset of the first symptom and diag-
nosis were significantly longer in multiple invasion (+) patients. 
The anemia markers were significantly higher in multiple inva-
sion (-) patients. Among 205 patients with multiply infected RBCs, 
151 patients showed RBCs with only two ring forms, and the max-
imum number of parasites per RBC was six in a patient. The mean 
proportion of RBCs infected by multiple ring forms among the 
total RBCs investigated in this study was 2.4% (with a minimum 
of 0.19% and a maximum of 11.2%; data not shown), which was 
less than the value ever observed in tropical zones (14).
  Among 353 gametocyte (+) patients, female gametocytes 
were found in 350 patients and male gametocytes in 194 pati-
ents (Table 4). Both female and male gametocytes were found 
in 191 patients (Group A), whereas only female gametocytes 
were found in 159 patients (Group B) and only male gameto-
cytes were found in three patients (Group C). The parasitemia 
was higher in Group A. The parasitemias of Groups A, B and C 
were 13,541, 4,699, and 2,533/µL, respectively. The gametocyte-
mia was also higher in Group A regardless of the gender of ga-
metocytes. The mean female gametocytemias of Group A and 
B were 2,063/µL and 595/µL, respectively, and the mean male 
gametocytemias of Group A and C were 169/µL and 26/µL, re-
spectively. Intervals between the onset of the first symptom and 
diagnosis of malaria in Group A, of which the parasitemia and 
the gametocytemia were higher than the other group, were lon-
ger than those in Group B and C. The intervals were 9.2, 8.1, and 
5.7 days in Groups A, B and C, respectively. During 2002 through 
2006 when the patients were enrolled in this study, annual differ-
ences of gametocytemia were not significant (data not shown).
DISCUSSION
Among the Plasmodium that can cause human malaria, P. falci-
parum has been studied most intensively while P. vivax has re-
ceived relatively little attention. Moreover, the majority of stud-
ies on P. vivax were performed with tropical strains. For investi-
gation of the parasitemia characteristics of P. vivax malaria in 
temperate regions, the Korean Peninsula is unique in that P. 
vivax malaria can be studied without confounding interactions 
with P. falciparum due to the complete absence of P. falciparum 
in this area. In ROK, P. vivax malaria occurred on a large scale 
for the past 17 yr (6, 8-10), and chemoprophylaxis with chloro-
quine and primaquine has been performed in the military since 
1997 (15).
  The number of cases observed in the 6 hospitals from 2002 to 
2006 (383 cases) accounts for 5.4% of the total cases reported in 
ROK during the same period (7,119 cases). Most of the patients 
enrolled in this study were civilians without prior exposure to 
the chemoprophylaxis, providing a good opportunity to investi-
gate the natural parasitemia characteristics without any signifi-
cant intervention. Interestingly, no child younger than 14 yr was 
enrolled during this study even though the 6 hospitals providing 
data were open to all ages. This made our study population dis-
tinct from tropical areas where P. vivax malaria was particularly 
prevalent in children and infants. The main reasons for paucity 
Table 4. Differences in parasitemia, gametocytemia and the interval between the first symptom onset and diagnosis according to the gender occurrence of gametocytes
Group
Female 
Gametocytes
Male 
Gametocytes
No. of 
Patients
Parasitemia  
( ± SD)
Gametocytemia  
( ± SD)
Female  
Gametocytemia  
( ± SD)
Male  
Gametocytemia  
( ± SD)
Interval (first 
symptom onset-
diagnosis) ( ± SD)
A (+) (+) 191 13,541/µL ( ± 20,146) 2,232/µL ( ± 3,066) 2,063/µL ( ± 2,925) 169/µL ( ± 240) 9.2 days ( ± 6.4)
B (+) (-) 159 4,699/µL ( ± 7,405) 595/µL ( ± 877) 595/µL ( ± 877) 0 8.1 days ( ± 5.8)
C (-) (+)     3 2,533/µL ( ± 1,599) 26/µL ( ± 17) 0 26/µL ( ± 17) 5.7 days ( ± 3.5)
Overall 353   9,465/µL ( ± 16,230) 1,476/µL ( ± 2,469) 1,385/µL ( ± 2,348)  92/µ L ( ± 196) 8.7 days ( ± 6.2)
Table 2. Differences in parasitemia and the interval between the first symptom onset 
and diagnosis according to the occurrence of gametocytes*
Parameters
Gametocytes
 P value   (+)  
  (n = 353; 92.2%)
  (-) 
  (n = 30; 7.8%)
Parasitemia (/µL)     9,465 ± 16,230   2,714 ± 6,907 < 0.001
Interval (first symptom  
   onset-diagnosis) (days)
  8.6 ± 6.1   5.8 ± 3.9 0.001
Red blood cell count  
   ( × 10
9/µL)
  4.0 ± 0.7   4.4 ± 0.6 0.004
Hemoglobin (g/dL) 12.1 ± 2.2 13.4 ± 1.9 0.002
Hematocrit (%) 35.3 ± 6.1 38.8 ± 5.4 0.002
*Values are the mean ± standard deviation.
Table 3. Differences in parasitemia and the interval between the first symptom onset 
and diagnosis according to the multiplicity*
Parameters
Multiplicity
 P value   (+)  
  (n = 205; 53.5%)
  (-) 
  (n = 178; 46.5%)
Parasitemia (/µL)   13,770 ± 19,224   3,370±7,392 < 0.001
Interval (first symptom  
   onset-diagnosis) (days)
  9.2 ± 6.5   7.5 ± 5.3 0.003
Proportion of asexual  
   parasites (%)
  83 ± 14   72 ± 26 < 0.001
Red blood cell count  
   ( × 10
9/µL)
  3.9 ± 0.7   4.2 ± 0.6 < 0.001
Hemoglobin (g/dL) 11.9 ± 2.3 12.6 ± 2.0 0.001
Hematocrit (%) 34.7 ± 6.3 36.6 ± 5.7 0.001
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of children patients in Korea may be unique population struc-
ture of Korean rural areas with very low percentages of younger 
people and low exposure chance to infected mosquitoes in them. 
Because children are far more populated in urban areas than in 
rural areas and they travel much less frequently to rural areas 
than adults do, they have less chance to be exposed to mosqui-
toes than adults.
  The mean parasitemia in this study was 8,396/µL, which is 
6.5 times higher than a previous study also performed in ROK 
(16). In that study, most of the enrolled patients were veterans 
who had received chemoprophylaxis before being discharged 
from the military, which might have resulted in suppression of 
parasitemia. The mean parasitemia of this study, however, was 
less than a half of P. vivax malaria in tropical zones (17, 18).
  Gametocytes were found in most of the patients enrolled in 
this study. The intervals between the first symptom onset and 
diagnosis were significantly longer in gametocyte (+) patients 
than in gametocyte (-) patients, which means that early case 
detection and treatment are important to block transmission. 
Parasitemias were significantly higher in gametocyte (+) patients 
than in gametocyte (-) patients, presumably due to the longer 
intervals. This result was similar to that of a previous study (13). 
The significantly lower levels of anemia indices in gametocyte 
(+) patients might be ascribed to the higher parasitemias, which 
means that the existence of gametocytes could be a coincident 
factor of the degree of anemia in P. vivax malaria regardless of 
their causal relationship. Data in Table 4 show that male game-
tocytes might appear in the hosts’ blood earlier than female ga-
metocytes, which was in agreement with a previous study (12).
  Male gametocyte densities have been believed to be critical 
in the infectivity of P. vivax (19). It might be ascribed to minor 
population of male gametocytes among total gametocytes. Un-
der this situation, it is more plausible that male gametocyte den-
sities play a key role to determine fertilization efficacy in Anoph-
eles mosquitoes. In this study, the proportion of male gameto-
cyte (+) patients among the enrolled patients and the ratio of 
male gametocytes to female gametocytes of group A were much 
lower than other P. vivax strains (12). In Group A, female game-
tocytes were 12 times more than male gametocytes. This ratio 
was 3-6 times higher than that of previous studies performed on 
P. vivax or P. falciparum (12, 20). Under the sex ratio shown in 
this study, it is difficult that male gametocytes can make enough 
flagellated gametes to fertilize female gametes to form zygotes. 
These findings may be one of plausible explanation for low trans-
mission efficacy of the P. vivax strain in ROK. Since the mid-
2000s, epidemiological characteristics of P. vivax malaria have 
been changed in ROK which raises the possibility of change of 
transmission efficacy (21). It is necessary to monitor gametocy-
temia annually since gametocytemia is strongly related to trans-
mission efficacy of Plasmodium.
  Most of the P. vivax malaria patients in ROK after re-emer-
gence have been primary infection cases without herd immu-
nity against P. vivax, because ROK was malaria-free for more 
than a decade. The diagnosis of malaria was usually determined 
at an early stage after illness in ROK since the primary infection 
cases probably have apparent symptoms and healthcare system 
has been working well in ROK. Despite the early diagnosis in 
ROK, gametocytes were found in 92% of the enrolled patients. 
The situation in North Korea is presumed to be similar to this 
result, which provides chances of active P. vivax malaria trans-
mission in the Korean Peninsula.
  Multiple invasions have been common in P. falciparum ma-
laria, but rarely described in P. vivax malaria (22). In general, P. 
falciparum malaria shows higher parasitemia than P. vivax ma-
laria, resulting in more mature schizonts, which can subsequ-
ently lead to more frequent multiple invasions (23). In this study, 
however, multiple infected RBCs were observed in as high as 
53.5% of the patients although the mean parasitemia was sub-
stantially lower than P. falciparum malaria. The ratio of patients 
with multiple infected RBCs in this study was also much higher 
than that observed in a tropical strain of P. vivax (24), support-
ing the previous speculation that multiple invasion in P. vivax 
malaria might not be directly related to parasitemia but could 
be a strain-specific characteristic (25). Parasitemias and the pro-
portion of asexual parasites among the total parasites were sig-
nificantly higher in multiple invasion (+) patients, which was 
similar to the result of a previous study (23). The parasitemia 
was significantly higher and the intervals between the first symp-
tom onset and diagnosis were significantly longer in the patients 
with multiple invasions. The data in Table 3 show that multiple 
invasion, like gametocytemia, is also a coincident factor of the 
degree of anemia in P. vivax malaria.
  In conclusion, the P. vivax strain in ROK reveals relatively low 
parasitemia and low male to female gametocyte ratio. The low 
male to female gametocyte ratio may be related with low trans-
mission efficacy. Early case detection and subsequent treatment 
are important to block transmission to vector mosquito.
 
ACKNOWLEDGMENTS
The authors thank Ms. Young-A Kim, Ms. Sun-Young Ahn, Ms. 
Mi-Young Shin and Ms. Ji-Ae Yoo for their technical support.
REFERENCES
1. Sachs J, Malaney P. The economic and social burden of malaria. Nature 
2002; 415: 680-5.
2. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax 
malaria: neglected and not benign. Am J Trop Med Hyg 2007; 77 (6 Sup-
pl): 79-87.
3. Hasegawa Y. Malaria in Korea. Chosun Igakkai Zasshi 1913; 4: 53-69.
4. Hankey DD, Jones R Jr, Coatney GR, Alving AS, Coker WG, Garrison PL, Huh A-J, et al.  •  Parasitemia Characteristics of P. vivax Malaria in Korea
46   http://jkms.org DOI: 10.3346/jkms.2011.26.1.42
Donovan WLWN. Korean vivax malaria. I. Natural history and response 
to chloroquine. Am J Trop Med Hyg 1953; 2: 958-69.
5. Paik YH, Ree HI, Shim JC. Malaria in Korea. Jpn J Exp Med 1988; 58: 55-66.
6. Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, Moon SH, Kim 
TS, Chai JY, Oh MD, Choe KW. Vivax malaria: a continuing health threat 
to the Republic of Korea. Am J Trop Med Hyg 2003; 69: 159-67.
7. Ree HI. Unstable vivax malaria in Korea. Korean J Parasitol 2000; 38: 
119-38.
8. Jun G, Yeom JS, Hong JY, Shin EH, Chang KS, Yu JR, Oh S, Chung H, Park 
JW. Resurgence of Plasmodium vivax malaria in the Republic of Korea 
during 2006-2007. Am J Trop Med Hyg 2009; 81: 605-10.
9. Yeom JS, Ryu SH, Oh S, Lee WJ, Kim TS, Kim KH, Kim YA, Ahn SY, Cha 
JE, Park JW. Status of Plasmodium vivax malaria in the Republic of Korea 
during 2001-2003. Am J Trop Med Hyg 2005; 73: 604-8.
10. Yeom JS, Kim TS, Oh S, Sim JB, Barn JS, Kim HJ, Kim YA, Ahn SY, Shin 
MY, Yoo JA, Park JW. Plasmodium vivax malaria in the Republic of Ko-
rea during 2004-2005: changing patterns of infection. Am J Trop Med 
Hyg 2007; 76: 865-8.
11. Eaton P. Susceptibility of red cells to malaria. Am J Trop Med 1934; 14: 
431-7.
12. McKenzie FE, Jeffery GM, Collins WE. Plasmodium vivax blood-stage 
dynamics. J Parasitol 2002; 88: 521-35.
13. McKenzie FE, Jeffery GM, Collins WE. Gametocytemia and fever in hu-
man malaria infections. J Parasitol 2007; 93: 627-33.
14. Simpson JA, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ. 
Red cell selectivity in malaria: a study of multiple-infected erythrocytes. 
Trans R Soc Trop Med Hyg 1999; 93: 165-8.
15. Yeom JS, Ryu SH, Oh S, Choi DH, Song KJ, Oh YH, Lee JH, Kim YA, Ahn 
SY, Yang HY, Cha JE, Park JW. Evaluation of anti-malarial effects of mass 
chemoprophylaxis in the Republic of Korea Army. J Korean Med Sci 2005; 
20: 707-12.
16. Oh MD, Shin H, Shin D, Kim U, Lee S, Kim N, Choi MH, Chai JY, Choe K. 
Clinical features of vivax malaria. Am J Trop Med Hyg 2001; 65: 143-6.
17. Collins WE, Sullivan JS, Jeffery GM, Williams A, Galland GG, Nace D, 
Williams T, Barnwell JW. The Chesson strain of Plasmodium vivax in 
humans and different species of Aotus monkeys. Am J Trop Med Hyg 
2009; 80: 152-9.
18. Sinden RE, Gilles HM. The malaria parasites. In: Warrell DA, Gilles HM, 
editors. Essential Malariology. 4th ed. London: Arnold, 2002,; p8-34.
19. Boyd MF, Kitchen SF. On the infectiousness of patients infected with Plas-
modium vivax and Plasmodium falciparum. Am J Trop Med 1937; 17: 
253-62.
20. Smalley ME, Sinden RE. Plasmodium falciparum gametocytes: their 
longevity and infectivity. Parasitology 1977; 74: 1-8.
21. Park JW. Changing transmission pattern of Plasmodium vivax malaria 
in the Republic of Korea: Relationship with climate change. Environ 
Health Toxicol 2011; 26: in press.
22. Hommel M. Diagnostic methods in malaria. In: Warrell DA, Gilles HM, 
editors. Essential Malariology. 4th ed. London: Arnold, 2002, p;35-58.
23. Wang CC. Multiple invasion of erythrocyte by malaria parasites. Trans 
R Soc Trop Med Hyg 1970; 64: 268-70.
24. Prasad RN, Prasad H, Virk KJ, Sharma VP. Detection of multiple invasion 
of erythrocytes by Plasmodium vivax. Trop Med Parasitol 1990; 41: 437-8.
25. Hingst HE. Erythrocyte susceptibility to Plasmodium vivax Grassi and 
Feletti, 1890. Am J Trop Med 1938; 18: 361-72.
AUTHOR SUMMARY
Parasitemia Characteristics of Plasmodium vivax Malaria Patients in the Republic 
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Parasitemia characteristics of Plasmodium vivax malaria in temperate regions may differ from those in tropical zones. However, 
most parasitological and clinical features of P. vivax malaria have been investigated in the latter. In this study, we investigated 383 
malaria patients to clarify the parasitemia characteristics of a P. vivax strain in the Republic of Korea (ROK). The mean parasitemia 
(8,396/µL) was less than half of tropical P. vivax malaria, and multiple invasions of erythrocytes were not rare (53.5% of the 
patients, 2.4% of the total investigated RBCs), but less than the observations in tropical zones. The intervals between the first 
symptom onset and diagnosis were significantly longer in gametocyte (+) patients than in gametocyte (-) patients. Only half of the 
total patients had both genders of gametocytes (191 out of 353), and the male gametocyte density (169/µL) was lower than the P. 
vivax strain of a previous study. Multiple invasions of erythrocytes and gametocytemia were coincident factors of the degree of 
anemia in P. vivax malaria. Results of this study showed the low parasitemia density and considerable gametocytemia of P. vivax 
malaria prevalent in ROK.